Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Equity: 2019-2025

Historic Return on Equity for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -0.40%.

  • Bicycle Therapeutics' Return on Equity fell 20.00% to -0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.40%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.30% for FY2024, which is 26.00% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Return on Equity stood at -0.40%, which was down 13.13% from -0.35% recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Return on Equity peaked at -0.20% during Q3 2024, and registered a low of -0.63% during Q2 2023.
  • In the last 3 years, Bicycle Therapeutics' Return on Equity had a median value of -0.40% in 2025 and averaged -0.39%.
  • Per our database at Business Quant, Bicycle Therapeutics' Return on Equity tumbled by 36bps in 2023 and then surged by 36bps in 2024.
  • Over the past 5 years, Bicycle Therapeutics' Return on Equity (Quarterly) stood at -0.26% in 2021, then declined by 17bps to -0.43% in 2022, then decreased by 3bps to -0.46% in 2023, then rose by 25bps to -0.22% in 2024, then dropped by 20bps to -0.40% in 2025.
  • Its Return on Equity stands at -0.40% for Q3 2025, versus -0.35% for Q2 2025 and -0.27% for Q1 2025.